Middle East & Africa Enteral and Parenteral Medical Nutrition Market

The Middle East & Africa enteral and parenteral medical nutrition market is expected to grow from US$ 539.80 million in 2023 to US$ 661.18 million by 2028. It is estimated to grow at a CAGR of 4.1% from 2023 to 2028.   

Specific Formulations and Plant-Based Nutrition Products Fuels Middle East & Africa Enteral and Parenteral Medical Nutrition Market

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the enteral and parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macro and micronutrient formulations of enteral and parenteral nutrition and its applications vary based on various diseases, such as cancer and gastrointestinal diseases. Isocaloric enteral nutrition formulation (1 kcal/ml) is generally prescribed to achieve estimated or measured caloric goals, while energy-dense formulae (>1 kcal/ml) are prescribed to increase calorie delivery in patients with gastrointestinal dysfunction.

Moreover, pharmaceutical companies provide enteral and parenteral nutrition with individualized (patient-specific) constituents. Standardized parenteral nutrition products contain fixed constituents and are designed to meet the average patient’s nutritional requirements considering different requirements in different age groups. These nutrition products can be sourced as institution-specific standardized formulations or patient-specific formulations. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing patients undergoing major elective surgeries to reduce postoperative complications and hospital stay duration and improve clinical outcomes. Peptamen Formula (Nestle) is the only peptide-based formula with enzymatically hydrolyzed 100% whey protein that helps overcome tube-feeding intolerance. Such tube-feeding formulas are specialized enteral nutrition products designed to support absorption and overcome tolerance mechanisms in individuals with gastrointestinal disorders.

Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are more likely to show intolerance to artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. Thus, the fewer ingredients, the better the final product. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. According to Abbott, consumers and patients relying on tube feeding are no exception to this trend. Companies in the enteral and parenteral medical nutrition market anticipate that a growing focus on healthy foods would translate into a preference for healthier nutrition products. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults. Similarly, olive oil-based parenteral nutrition products are also gaining popularity.

Therefore, functional, and patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral and parenteral medical nutrition market.

Middle East & Africa Enteral and Parenteral Medical Nutrition Market Overview

The Middle East & Africa enteral and parenteral medical nutrition market is categorized into the UAE, Saudi Arabia, South Africa, Iran, Israel, Egypt, and the Rest of Middle East & Africa. In 2021, Saudi Arabia held a significant share of the enteral and parenteral medical nutrition market in the region. The enteral and parenteral medical nutrition market is expected to grow due to the increasing cases of cancer and stroke, as well as growing malnutrition among adults and premature babies across the region. Moreover, the growing government initiatives in the region propels the market growth.

 Middle East & Africa Enteral and Parenteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Enteral and Parenteral Medical Nutrition Market Segmentation

The Middle East & Africa enteral and parenteral medical nutrition market is segmented into indication, nutrition type, form, product type, route of administration, age group, and distribution channel, and country.

Based on indication, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held the largest share of the Middle East & Africa enteral and parenteral medical nutrition market in 2023. Gastrointestinal disorders are segmented into IBD, IBS, and others.

Based on nutrition type, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held a larger share of the Middle East & Africa enteral and parenteral medical nutrition market in 2023.

Based on form, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held the largest share of the Middle East & Africa enteral and parenteral medical nutrition market in 2023.

Based on product type, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held the largest share of the Middle East & Africa enteral and parenteral medical nutrition market in 2023.

Based on route of administration, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held the largest share of the Middle East & Africa enteral and parenteral medical nutrition market in 2023.

Based on age group, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held the largest share of the Middle East & Africa enteral and parenteral medical nutrition market in 2023.

Based on distribution channel, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest share of the Middle East & Africa enteral and parenteral medical nutrition market in 2023

Based on country, the Middle East & Africa enteral and parenteral medical nutrition market is segmented into Saudi Arabia, South Africa, the UAE, Iran, Israel, Egypt, and the Rest of Middle East & Africa. Saudi Arabia dominated the share of the Middle East & Africa enteral and parenteral medical nutrition market in 2023.   

Abbott Laboratories; B. Braun SE; Baxter International Inc; Easy Line Ltd; Fresenius Kabi AG; Nestle SA; and Nutricia International BV are the leading companies operating in the Middle East & Africa enteral and parenteral medical nutrition market.    

Middle East & Africa Enteral and Parenteral Medical Nutrition Market Strategic Insights

Middle East & Africa Enteral and Parenteral Medical Nutrition Market Segmentation Analysis

Middle East & Africa Enteral and Parenteral Medical Nutrition Market Report Highlights

Middle East & Africa Enteral and Parenteral Medical Nutrition Report Scope

Middle East & Africa Enteral and Parenteral Medical Nutrition Market Country and Regional Insights